India, Feb. 1 -- A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate,cb1, capable of generating broad immunity ...

The Lambda variant is one of 11 official SARS-CoV-2 variants recognised by the World Health Organization. It was first ...

The CDC has 1 million participants in its travel bio surveillance program, 'marking a significant milestone in the United States' ability to detect and respond to emerging public health threats.' ...

Researchers discovered that digested SARS-CoV-2 spike protein fragments selectively attack certain immune cells, reducing ...

This article examines the state of public health in the United States in January 2026, detailing mass COVID-19 infection, excess deaths, collapsing vaccination coverage, immune damage and the ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

SK bioscience announced the initiation of a global Phase 1/2 clinical trial in Australia for GBP511, a vaccine candidate ...

The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.

Key takeawaysA UCLA-led research team demonstrated that when human immune enzymes break up the spike protein of the virus ...

Millions of COVID-19-associated illnesses and outpatient visits as well as thousands of hospitalizations and deaths continued to occur annually in the United States from late 2022 through 2024, ...

Qiagen is a consumable molecular diagnostics and life-science tools platform and offers QuantiFERON, QIAstat-Dx, QIAcuity ...

While the current findings suggest that exposure to COVID in utero is not associated with neurocognitive outcomes at 12 ...